CD4 and cancer: Together with our data, these studies suggest that CD4 T cells recognizing antigens on tissue-resident APCs can be important modifiers of the inflammatory processes that can drive (or protect from) not only cancer but also other types of diseases, accentuating the importance of studying CD4 T cell–TAM interactions to harness them for future clinical treatments.